Literature DB >> 32127248

Beyond the hashtag - An exploration of tweeting and replies at the European Society of Surgical Oncology 39th clinical conference (ESSO39).

Graham Mackenzie1, Kjetil Søreide2, Karol Polom3, Laura Lorenzon4, Helen Mohan5, Delia Cortés Guiral6, Julio Mayol7.   

Abstract

INTRODUCTION: Previous studies of conference tweeting have focused on tweets that used the conference hashtag. The aim of this study was to document responses beyond a specific conference hashtag.
METHODS: Observational study exploring replies to tweets for the 39th meeting of ESSO (ESSO39), Rotterdam, 9-11 October 2019. An extract of #ESSO39 tweets was obtained using NodeXL. Replies to these tweets were identified by viewing the tweets via Twitter.com.
RESULTS: There were 210 tweets posted using the #ESSO39 hashtag by 64 tweeters. However, extending the analysis to include responses that did not use the hashtag, tweets using the hashtag only represent 54% of all tweets posted or quoted at the conference, and only 49% of the tweeters posting content or quoted in tweets. Based on this study of ESSO39 therefore roughly half of tweets and contributors to conference tweeting were not captured by focusing simply on the conference hashtag (#ESSO39). Mentioning another tweeter(s) in a tweet or response was associated with more retweets, as was including the hashtag in replies.
CONCLUSIONS: Twitter activity at medical conferences extends beyond the conference hashtag. Almost half of the tweeting was beyond the hashtag. To increase visibility of tweets, conference delegates should include the conference hashtag and mention other tweeters in their tweets and responses. Searching for tweets is an active process requiring users to click into replies. Twitter and third-party social media tools should improve identification and display of responses, showing the branching structure of replies and quoting tweets in real time.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Conference; Education; Social media

Mesh:

Year:  2020        PMID: 32127248     DOI: 10.1016/j.ejso.2020.02.018

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Impact of Randomized Controlled Trials in the Social Media: Does Science Trend As Much As Everyday Events?

Authors:  Laura Lorenzon; Rebecca C Grossman; Kjetil Soreide
Journal:  World J Surg       Date:  2020-09-05       Impact factor: 3.352

Review 2.  Social Media and Professional Development for Oncology Professionals.

Authors:  Anusha Chidharla; Audun Utengen; Deanna J Attai; Emily K Drake; G J van Londen; Ishwaria M Subbiah; Elizabeth Henry; Martina Murphy; Maura M Barry; Rami Manochakian; Scott Moerdler; Stacy Loeb; Stephanie L Graff; Yan Leyfman; Michael A Thompson; Merry J Markham
Journal:  JCO Oncol Pract       Date:  2022-03-21

3.  ACC.20: Impact of social media at the virtual scientific sessions during the COVID-19 pandemic.

Authors:  Graham Mackenzie; Martha Gulati
Journal:  Clin Cardiol       Date:  2020-07-03       Impact factor: 2.882

4.  Enhancing engagement beyond the conference walls: analysis of Twitter use at #ICPIC2019 infection prevention and control conference.

Authors:  Romain Martischang; Ermira Tartari; Claire Kilpatrick; Graham Mackenzie; Vanessa Carter; Enrique Castro-Sánchez; Hilda Márquez-Villarreal; Jonathan A Otter; Eli Perencevich; Denise Silber; Julie Storr; Jason Tetro; Andreas Voss; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-25       Impact factor: 4.887

5.  Beyond the hashtag: describing and understanding the full impact of the #BJSConnect tweet chat May 2019.

Authors:  G Mackenzie; R Grossman; J Mayol
Journal:  BJS Open       Date:  2021-03-05

6.  Full Abstract to Published Manuscript: Evaluation of the Scientific Impact of the American Society of Breast Surgeons Conference.

Authors:  Zachary J Brown; Amy Li; Chengli Shen; Ko Un Park
Journal:  Ann Surg Oncol       Date:  2021-07-21       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.